KDR and melanoma: Therefore, we hypothesized that the encapsulation of VEGFR-2 peptides in nanoliposomal formulations might be a potential immunization strategy for enhancing the antitumor immunity against VEGFR-2 overexpressing melanoma tumors in the C57BL/6 mice model.